Close Menu

rituximab

A Case of EBV-associated T/B Cell Lymphoproliferative Disease Successfully Treated with R-CVP

DOI: 
10.7727/wimj.2016.209

ABSTRACT

Accepted: 
10 Jun, 2016
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 14 Jul, 2016

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Treatment of One Case with Cryoglobulinaemia Secondary to Connective Tissue Disease by Small Doses of Rituximab

Issue: 
DOI: 
10.7727/wimj.2014.384
Pages: 
398-400

Abstract

Objective: This study aims to observe the clinical efficacy of low-dose rituximab patients with cryoglobulinaemia secondary to connective tissue diseases.

Methods: Rituximab (100 mg) was infused in patients once a week for four weeks, combined with prednisone (20 mg) once a day and reduced regularly. The treatment effect was observed regularly.

Accepted: 
06 Jan, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 04 Apr, 2016
Subscribe to RSS - rituximab
Top of Page